Supply Chain

A coalition of nine consumer advocacy groups sent a letter to the Federal Trade Commission Nov. 22 urging it to open an antitrust investigation into group purchasing organizations.

Here are four medical device recalls the FDA reported in November: 

Value-based care pressures are pushing many healthcare supply chain leaders to launch a new approach to operations—one that prioritizes risk management and cost control at scale without sacrificing care quality or outcomes.

Blood bag shortages nationwide, particularly for the only universal blood type, O-negative, has been causing organizations to issue an urgent appeal to donors, multiple sources report.

Shortages of medications used to treat common childhood illnesses are placing added stress on parents, pharmacists and clinicians navigating an already challenging respiratory virus season, CNN reported Nov. 22.

From April 2021 to Oct. 31, 2022, Philips Respironics has reported 260 deaths to the FDA as part of its recall of 3.5 million ventilators after a foam breakdown was pushing black debris into inhalation tubes. 

Here are 10 health systems and hospitals that posted job listings seeking supply chain expertise in the last week. 

In a Nov. 22 alert, the FDA told physicians that some Luer-activated valve connectors with internal pin designs aren't compatible with prefilled glass syringes, and if they're forced together, the drug can become clogged. 

About two weeks after the American Red Cross issued a warning about a severe flu season hindering blood supply, multiple states are facing critical shortages. 

Insulet recalled 248,288 insulin deployment devices after receiving three reports of fires and more than 400 complaints about the product's batteries swelling, leaking and overheating.